Anticoagulants Market Size, Share, Growth Analysis, By Drug class(Vitamin K Antagonists (VKAs) and Direct Oral Anticoagulants (DOACs)), By Distribution channel(Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region - Industry Forecast 2024-2031

The Global Anticoagulants Market size size was valued at USD 28.50 Billion in 2022 and is poised to grow from USD 31.44 Billion in 2023 to USD 68.87 Billion by 2031, at a CAGR of 10.30% during the forecast period (2024-2031). 

The rise in the incidence of severe and critical illnesses worldwide is contributing to the market's expansion. Modern lifestyle changes are the primary cause of the rising frequency of cardiovascular illnesses worldwide. Life-threatening disorders like hypertension, coronary heart disease, and hyperlipidemia are associated with cardiovascular illness of the heart and blood arteries. It may cause strokes or heart attacks. Cardiovascular medications with an anticoagulant component can be used to treat the majority of cardiovascular diseases. Blood clots are more likely to form when these anticoagulants are absent from the medications that are given to patients. 

One of the main reasons propelling the growth, according to the global anticoagulants market forecast during the forecast period is the rising prevalence of heart illnesses and the rising need for blood thinners. Anticoagulants underwent a number of research and development advancements prior to being put on the market. Novel medications like NOACs have a very high commercial success rate from the moment of debut. Xarelto and Eliquis are the two most popular coagulants available on the market. The market's expansion is anticipated to be hampered by the widespread availability of generics and other anticipated coagulant launches.

US Anticoagulants Market is poised to grow at sustainable CAGR for the next forecast year.